NCT06677151
NPA-OSA Device Tolerability, Usability and Acclimation Clinical Study in Adult Obstructive Sleep Apnea (OSA) Patients
At risk: Primary completion moved at least 11 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 6 versions: 4 with changes below, 2 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Notable Primary completion pushed from Oct 2026 to Oct 2027
- Eligibility criteria expanded, about 20 words
- Study completion pushed from Dec 2026 to Dec 2027
- Site contacts updated at 2 of 2 sites
- Notable Primary completion date: Mar 2026 to Oct 2026
- Study completion date: Mar 2026 to Dec 2026
- Site contacts updated at 1 of 2 sites
Notable Lead sponsor: [Redacted] to University of Michiganv4 Show 5 more changesShow less
- Trial status: Withheld to Recruiting
- Primary and study completion dates: Mar 2026
- Start date: Mar 7, 2025
- Collaborators expanded, about 7 words
- Study title expanded, about 2 words
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Change in severity of apnea hypopnea index (AHI)
Timeframe: Baseline (day 0), 30 days
Arms and interventions
Nasopharyngeal airway deviceExperimental
A nasopharyngeal airway obstructive sleep apnea ("NPA"-OSA) device will be used for one night in a sleep laboratory and 30 days at home.
Devices: nasopharyngeal airway obstructive sleep apnea (NPA-OSA) device
Sites
2 sites in 1 country